Results 151 to 159 of about 4,918 (159)

Vildagliptin

Drugs of the Future, 2004
null McIntyre, J.A., null Castaner, J.
openaire   +1 more source

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin

Diabetes, Obesity and Metabolism, 2009
Francesco Dotta
exaly  

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Diabetes, Obesity and Metabolism, 2013
exaly  

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea*

Diabetes, Obesity and Metabolism, 2008
exaly  

Vildagliptin protects endothelial cells against high glucose-induced damage

Biomedicine and Pharmacotherapy, 2018
exaly  

Clinical effectiveness and safety of vildagliptin in >19 000 patients with type 2 diabetes: the GUARD study

Diabetes, Obesity and Metabolism, 2015
exaly  

Vildagliptin

Reactions Weekly, 2015
openaire   +1 more source

Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response

Diabetes, Obesity and Metabolism, 2005
exaly  

P19-52 In silico and in vitro genotoxicity evaluation of vildagliptin impurities: vildagliptin cyclic amidine, vildagliptin diketopiperazine and vildagliptine amide

Toxicology Letters
M. Hamitoğlu, G. Tugcu, A.G. Kılıç, G. Esen, A. Aydın   +4 more
openaire   +1 more source